BioSpace News Archive

Business

Nobilis Health Reports Fourth Quarter and Full Year 2017 Financial Results

Full year total revenue of $299.7 million, a 4.9% increase over prior year

March 8, 2018
·
26 min read
Business

Walgreens Boots Alliance Appoints James Kehoe Global Chief Financial Officer

Kehoe takes over from George Fairweather, who played a key role in the Walgreens-Alliance Boots merger and subsequent integration and development, and has decided to step down after a combined 16 years in the senior finance leadership position in Walgreens Boots Alliance and legacy companies.

March 8, 2018
·
6 min read
Biotech Bay

Eyenuk, Inc. Receives Health Canada Approval for EyeArt™, an AI-enabled Cloud-based Automated Diabetic Retinopathy Screening Software

Building upon Eyenuk’s successful launch in Europe, this Health Canada license supports Eyenuk’s objective to expand the global availability of EyeArt™ to more clinicians seeking tools for improved screening of diabetic retinopathy in their patients at the point of care.

March 8, 2018
·
4 min read
Business

Varex Imaging Names Managing Director For China Along With Consolidation Of Operations In China

Varex has consolidated all of its operations in China under the leadership of Shaohua Liang.

March 8, 2018
·
2 min read
Business

EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research

Programme aims to advance knowledge in type 1 diabetes with support for research projects over three years.

March 8, 2018
·
4 min read
Business

BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017

2017 was a very productive year for BrainStorm, with significant progress and achievements across clinical, operational and financial fronts.

March 8, 2018
·
13 min read
Business

What Are These Retired Special Forces Soldiers’ Next Target? LEAD.

Artemis Shielding is revolutionizing the radiation shielding industry with a lighter, safer and more precise lead alternative.

March 8, 2018
·
2 min read
Genetown

Cyteir Therapeutics Secures $29 Million Series B to Advance Novel, Molecularly Targeted Therapies for Cancer and Autoimmune Diseases

Financing proceeds will be used to advance RAD51 inhibitor toward the clinic and expand small-molecule synthetic lethality platform for oncology and autoimmune diseases.

March 8, 2018
·
5 min read
Pharm Country

NHF Launches 2018 Red Tie Campaign to Protect Access to Affordable, Quality Healthcare for People with Bleeding Disorders

NHF marks Bleeding Disorders Awareness Month and its 70th anniversary on March 8 with advocacy event on Capitol Hill

March 8, 2018
·
5 min read
Business

Seres Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates

Positive SER-287 Phase 1b clinical and microbiome results support further development; Company plans to initiate next clinical trial in mid-2018.

March 8, 2018
·
16 min read